Aloxi (palonosetron) is the newest drug for preventing chemotherapy-related nausea and vomiting
Aloxi (palonosetron) is the newest drug for preventing chemotherapy-related nausea and vomiting.
Aloxi is a 5-HT3 antagonist...similar to Zofran (ondansetron), Anzemet (dolasetron), and Kytril (granisetron).
But Aloxi has a much longer half-life...about 40 hours... compared to less than 8 hours for the others.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote